Beta-amyloid, human

Beta-amyloid, which is also referred to as Aβ, is a peptide that is derived from the amyloid precursor protein. It is one of the most established biomarkers for the progression of Alzheimer’s disease (AD).


Special Offer!
Evaluate
Neuroscience MAbs
0,5mg of each FOC*
Read more and
order below >>

The accumulation of the extracellular beta-amyloid protein (which is also referred to as Aβ plaques) is one fundamental neuropathological hallmark of AD. To date, beta-amyloid is considered as being one of the most established biomarkers for the progression of AD.

Among the various beta-amyloid isoforms found in CSF, Aβ42 is considered as one of the key pathological biomarkers in terms of assessment for AD diagnosis. Aβ42 forms aggregation into fibrils and extracellular plaques in the brain, resulting in a lower level of Aβ42 in the CSF. Therefore, Aβ42 provides a predictive value for AD, which can be used in both the prodromal and dementia stage of AD.

At HyTest, we provide a selection of well­characterized mouse monoclonal antibodies for the detection of Aβ42 in human CSF. These antibodies were developed against synthetic peptides that correspond to fragments of the Aβ42 sequence.

Learn more:
Cat# 4BA3:Beta-amyloid, human, antibody

undefined

*Offer and Terms: Offer valid 01–04/23. When ordering online, write NEURO to the remarks field. The campaign is not valid for antigens. The special offer opportunity is only available to end users. Institutes and universities are not included in this promotion. The usual shipping and handling costs will still apply. Select invoice or prepayment invoice as a payment method on the checkout page. The opportunity is a one-time evaluation possibility, feedback about the evaluation results is expected and you can get more details by contacting HyTest customer service at hytest@hytest.fi

 

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!